Literature DB >> 12606914

Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs.

Karl H Stadlbauer1, Horst G Wagner-Berger, Claus Raedler, Wolfgang G Voelckel, Volker Wenzel, Anette C Krismer, Guenter Klima, Klaus Rheinberger, Walter Nussbaumer, Daniel Pressmar, Karl H Lindner, Alfred Königsrainer.   

Abstract

BACKGROUND: The authors compared the effects of vasopressin fluid resuscitation on survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs.
METHODS: A midline laparotomy was performed on 23 domestic pigs, followed by an incision, and subsequent finger fraction across the right medial liver lobe. During hemorrhagic shock, animals were randomly assigned to receive either 0.4 U/kg vasopressin (n = 9), or fluid resuscitation (n = 7), or saline placebo (n = 7), respectively. A continuous infusion of 0.08 U x kg(-1) x min(-1) vasopressin in the vasopressin group, or normal saline was subsequently administered in the fluid resuscitation and saline placebo group, respectively. After 30 min of experimental therapy, bleeding was controlled by surgical intervention, and blood transfusion and rapid fluid infusion were subsequently performed.
RESULTS: Maximum mean arterial blood pressure during experimental therapy in the vasopressin-treated animals was significantly higher than in the fluid resuscitation and saline placebo groups (mean +/- SD, 72 +/- 26 vs 38 +/- 16 vs 11 +/- 7 mmHg, respectively; P< 0.05). Subsequently, mean arterial blood pressure remained at approximately 40 mmHg in all vasopressin-treated animals, whereas mean arterial blood pressure in all fluid resuscitation and saline placebo pigs was close to aortic hydrostatic pressure (approximately 15 mmHg) within approximately 20 min of experimental therapy initiation. Total blood loss was significantly higher in the fluid resuscitation pigs compared with vasopressin or saline placebo after 10 min of experimental therapy (65 +/- 6 vs 42 +/- 4 vs 43 +/- 6 ml/kg, respectively; P< 0.05). Seven of seven fluid resuscitation, and seven of seven saline placebo pigs died within approximately 20 min of experimental therapy, while 8 of 9 vasopressin animals survived more than 7 days (P < 0.05).
CONCLUSIONS: Vasopressin, but not fluid resuscitation or saline placebo, ensured survival with full recovery in this liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606914     DOI: 10.1097/00000542-200303000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  22 in total

1.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 2.  [Treatment of hemorrhagic shock. New therapy options].

Authors:  W G Voelckel; A von Goedecke; D Fries; A C Krismer; V Wenzel; K H Lindner
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

3.  Cerebral effects of resuscitation with either epinephrine or vasopressin in an animal model of hemorrhagic shock.

Authors:  Jan Küchler; Stephan Klaus; Ludger Bahlmann; Nils Onken; Alexander Keck; Emma Smith; Jan Gliemroth; Claudia Ditz
Journal:  Eur J Trauma Emerg Surg       Date:  2019-05-24       Impact factor: 3.693

4.  Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.

Authors:  Carrie A Sims; Daniel Holena; Patrick Kim; Jose Pascual; Brian Smith; Neils Martin; Mark Seamon; Adam Shiroff; Shariq Raza; Lewis Kaplan; Elena Grill; Nicole Zimmerman; Christopher Mason; Benjamin Abella; Patrick Reilly
Journal:  JAMA Surg       Date:  2019-11-01       Impact factor: 14.766

5.  Fluid sparing and norepinephrine use in a rat model of resuscitated haemorrhagic shock: end-organ impact.

Authors:  Sophie Dunberry-Poissant; Kim Gilbert; Caroline Bouchard; Frédérique Baril; Anne-Marie Cardinal; Sydnée L'Ecuyer; Mathieu Hylands; François Lamontagne; Guy Rousseau; Emmanuel Charbonney
Journal:  Intensive Care Med Exp       Date:  2018-11-12

6.  [Vasopressin for therapy of persistent traumatic hemorrhagic shock: The VITRIS.at study].

Authors:  H G Lienhart; V Wenzel; J Braun; V Dörges; M Dünser; A Gries; W R Hasibeder; M Helm; R Lefering; T Schlechtriemen; H Trimmel; H Ulmer; W Ummenhofer; W G Voelckel; C Waydhas; K Lindner
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

7.  Porcine anaesthesia for advanced trauma operative management (atom).

Authors:  H Baddoo; F Ahiaku; E Fordjuor; I Wulff; D Akuoku; D Kwami
Journal:  Ghana Med J       Date:  2008-09

8.  Vasopressin treatment of verapamil toxicity in the porcine model.

Authors:  J Dave Barry; Dave Durkovich; Lee Cantrell; William Richardson; Tri Tong; Steve Offerman; Richard F Clark; David A Tanen; Saralyn Williams
Journal:  J Med Toxicol       Date:  2005-12

Review 9.  [New therapeutic approaches in the treatment of shock: hypertonic hyperoncotic solutions and vasopressin].

Authors:  A Meier-Hellman; G Burgard
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

10.  [Traumatic thoracic aorta rupture: preclinical assessment, diagnosis and treatment options].

Authors:  R Kopp; J Andrassy; S Czerner; A Weidenhagen; R Weidenhagen; G Meimarakis; M Reiser; K W Jauch
Journal:  Anaesthesist       Date:  2008-08       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.